The structure of the metalloproteinase and hemorrhagic toxin atrolysin C form d (EC 3.4.24.42), from the venom of the western diamondback rattlesnake Crotalus atrox, has been determined to atomic resolution by x-ray crystallographic methods. This study illuminates the nature of inhibitor binding with natural (<Glu-Asn-Trp, where <Glu is pyroglutamic acid) and synthetic (SCH 47890) ligands. The primary specificity pocket is exceptionally deep; the nature of inhibitor and productive substrate binding is discussed. Insights gained from the study of these complexes facilitate the design of potential drugs to treat di where matrix metalloproteinases have been implicated, e.g., arthritis and tumor metastasis.
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Hemorrhagic metalloproteinases (MPs) from the western diamondback rattlesnake Crotalus atrox are members of the reprolysin subfamily of zinc MPs (1), which includes venom MPs and the mammalian reproductive proteins, e.g., PH30 isolated from guinea pig sperm (2) . Venom proteinases can be divided into four classes (P-I to P-IV) that minimally share homologous (P-I) proteinase domains; classes P-II to P-IV have additional domains located C-terminal to the proteinase domain (3) . Atrolysin C (EC 3.4.24.42) is the trivial name given to C. atrox hemorrhagic isoenzymes [forms c and d (Ht-c and d, respectively) class P-I, 202 amino acids, 1 Zn, and 1 Ca] that differ by only 1 amino acid (Ala-180 -* Asp;
refs. 3 and 4) . Ht-d efficiently cleaves basement membrane proteins surrounding capillaries, permitting the flux of capillary contents into the surrounding stroma, producing hemorrhage (5) , and toxins into the circulatory system. Enzymatic activity, hence hemorrhage, can be inhibited by removal of the zinc atom, by synthetic inhibitors (6) , by endogenous venom peptides [<Glu-Asn-Trp (where <Glu is pyroglutamic acid) = pENW], or by human a2-macroglobulin (7, 8) .
The reprolysins share some structural similarities with the other zinc MP subfamilies, including the matrix MPs (MMPs), the astacins, and the serralysins (large bacterial proteinases), primarily in the region of the zinc binding site (9) . Both the reprolysins and the MMPs appear to maintain enzyme latency by the mechanism of a "cysteine switch," a short consensus sequence found in the pro-domains of these proteinases with a common Cys-Gly-Val locus, that interacts with active-site zinc effectively preventing substrate binding (1, 10) . Functionally, both the reprolysins and the MMP members seem to be primarily involved in the hydrolysis of extracellular matrix (1, 11) , based on common structural features.
The crystal structure of a class P-I native venom MP, adamalysin II, from Crotalus adamanteus (EC 3.4.24.46;  80% sequence similarity to Ht-d) has been described (12) , as was the native digestive MP, astacin (13) . A high degree of tertiary structure conservation among the astacin, reprolysin, serralysins, and the MMP subfamilies is observed (9, 14) at the active site, suggesting that the structural principles that govern the interaction of substrates and inhibitors with members of these subfamilies are likely to be similar if not identical. Substrates and synthetic inhibitors of the MMPs have been discussed (15) (27) , docked into the AF map by using the program FRODO, together with 143 discernable water molecules, and refined (R = 17.4%; Fig. 3 ).
pENW Refinement. A native crystal was soaked for 7 h in a buffered solution of 1 (20 mg/ml) ( Table 1 ). The empty model was used as a starting point for the analysis of the pENW complex. Compound 1 was modeled (27) and docked into the AFmap. A regionally (8 A) restrained simulated annealingplus omit map regimen (X-PLOR 3.0) was used to remove possible bias in the active site. With 149 water molecules added, the structure refined to R = 17.1% (Table 1 and Fig. 4) .
Native Ht-d (NATI) Structure. The empty model was refined and used to calculate a AF map (Fig. 5 ) that surprisingly contained a pronounced active-site density that was strikingly similar to the pENW ligand in shape and location and was duplicated in both molecules in the asymmetric unit. This is reminiscent of a peptidic ligand located in native y-chymotrypsin (28 (30) and thus an ideal target for structure-based rational drug design. Excluding the less-well-determined termini, the greatest shift (1.5 A) occurs at the backbone of residue 169 at the S2' site (31); neighboring shifts are less than 1 A.
In both SCH and pENW, a common H bond (from Asn-108) is observed and an 0 atom of the inhibitor occupies the apical tetrahedral coordination locus of Zn, displacing a water molecule in the native structure. Ht-d exhibits a structural similarity to adamalysin II (12) and a human collagenase (9, 14) , which establishes the characteristic folding pattern of MMPs. Significant characteristics include the following features: (i) The "active-site helix" (residues 132-147), with Zn ligands (His-142 and His-146), a sharp turn (residues 148-151), the third His ligand (His-152), and ubiquitously conserved Met (Met-166), which forms the "basement" of the Zn locus ("Met turn") and, (ii) thus, helps anchor the essential strand (residues 168-172), with Pro-168 conserved in both venom and mammalian MMPs. This strand forms one wall of the extended binding site (Figs. 2-5) . (iii) The other wall of the extended binding site is defined by the antiparallel (3-strand (IV, residues 106-114). Substrate binding may be predicted to be dominated to a large degree by individual residues in these two strands and the active-site-D helix. A third parallel strand (residues 152-157, Figs. 1 and 2 ) may be postulated to define a second extended binding site, possibly to accommodate an additional collagen peptide chain.
With predominant van der Waals contacts to both ligands, the S1' primary specificity site containing the indole ring of TIp (1) and Ile) residues. This agrees with the reported hydrolysis by type IV collagenase (gelatinase) of a scissile Gly-Tyr bond (31) in type I collagen and by stromelysin ofthe Gln-Phe bond (32) , confirming the assignment of the Si' pocket and thus providing a prime component for inhibitor design. The bottom of the S1' pocket is occupied by conserved hydrophobic residues (e.g., Val-138 and Ile-165), ca. 10 A from P1' Ca. Sequence comparisons reveal that the amino acids defining the extended binding site are generally hydrophobic, excepting the pronounced water-filled channel (Fig. 4) , which links the deep SP' pocket with the exterior of the protein, suggesting a mechanism for entropic displacement of bound water (33) .
Comparisons. The hemorrhagic isozymes (a-e) of the venom MMP from C. atrox have been shown to cleave type IV collagen (4), one of the major structural components of basement membranes, which both compartmentalizes tissues (e.g., capillaries) and provides signals for cell differentiation (34) . Substrate specificity (34) (35) (36) (37) (38) for collagen helps characterize the various MMP species and can provide insight for the design of specific inhibitors. Type IV collagenases play crucial roles (38) in both beneficial (cell growth and differentiation, remodeling, wound healing, angiogenesis, etc.) and pathological (periodontitis, rheumatoid arthritis, inflammation, and tumor metastasis) processes.
Interstitial and neutrophil collagenases (39) are ineffective against type IV collagen in the basement membrane, which is degraded by type IV collagenase (40) . Collagens (e.g., types I, 1, III, and X) are characterized as tightly wound triple helices; each chain of the triple helix in type IV collagen has [21] [22] [23] [24] interruptions of the Gly-Xaa-Yaa repeat (41) , which are generally more sensitive to proteolysis; Yaa is usually Pro or hydroxyproline. Collagenases usually cleave a specific GlyXaa bond, with Xaa a hydrophobic residue at S1' (35) ; this is confirmed (32) for stromelysin (MMP-3), where model compound assays probed the pronounced hydrophobic nature of the extended binding site region (S3-S2'). Tumor-cell penetration of the extracellular matrix is one of the factors in metastasis that is linked to type IV collagenase action (16, 18 (ii) The dominant primary specificity site (Si') can contain large aromatic or extended hydrophobic moieties, up to a length (from Ca) of 9-10 A.
(iii) Based on sequence comparisons, the MMPs have similar hydrophobic active site and extended binding site characteristics.
(iv) Hydrophilic groups will generally occupy surface loci, pointing "out" into the hydrated surface (rather than into the hydrophobic extended binding site).
(v) The extended binding site has charged groups (e.g., Lys-172) at both ends.
For small molecule inhibitors, two factors dominate binding: Zn ligation and optimal (i.e., size/shape dependent) van der Waals interactions. The anomalous micromolar binding of a tripeptide inhibitor (e.g., pENW) deserves special attention.
These analyses describe the geometric characteristics of venom MP binding to two inhibitors, providing initial insight into the active-site preferences of MMPs. Because venom and mammalian enzymes possess functional and structural similarities, the venom enzymes Ht-d and adamalysin II are candidates for the development of physiologically useful compounds to help control diseases associated with aberrant regulation of collagenases. While it is now possible to create models of putative complexes based on these structures, experience (47) with the vagaries of binding of small molecule ligands reinforces the necessity of experimental confirmation of any such model, due to the ever-present possibility of alternative binding modes of small-molecule inhibitors. These analyses provide geometric insight into enzymesubstrate interactions and illumination for the design of improved inhibitors and therapeutics.
